Present Status and Future Prospects for Adjuvant Therapy of Melanoma: Time to Build upon the Foundation of High-dose Interferon Alfa-2b
Year: 2003
Type: editorial
Source: Journal of Clinical Oncology
Institutions: UPMC Hillman Cancer Center, SUNY Upstate Medical University
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2121932300
